THE AI FOR MEDICINE

Empower Precision Medicine with Candes AI

VISION

We’re Transforming the Way of Translational Medicine

We are dedicated to understanding patterns and mechanisms of diseases. Our goal is to make therapy work for all patients. We use advanced bioinformatics and multimodal machine learning to discover novel biomarkers, new targets, and treatment criteria that can improve diagnostic and treatment outcomes. Our AI-enabled, multiscale platform coalesces high-dimensional disease and drug properties to help us achieve this mission.

Research & Development

We Enhance Disease Diagnosis and Treatment with AI

IMPROVED TRIALS

Our multiscale high-precision subtyping is a promising approach to improve clinical trial recruitment. By identifying subgroups of patients with similar characteristics, researchers can tailor their recruitment strategies to better target those who are most likely to benefit the trial. This can lead to more efficient and effective clinical trials, ultimately benefiting patients and advancing medical research.

TARGETED THERAPY

Advanced drug identification powered by AI technology offers a high-precision solution for targeted therapy. By leveraging patient-specific genetic and clinical data, it offers personalized treatments that are tailored to patients' unique needs. Our state-of-the-art approach enables healthcare providers to improve patient outcomes and deliver the highest quality of care.

ACCURATE DIAGNOSTICS

Multimodal biomarkers are a promising avenue for early detection and diagnostics. By combining multiple types of data, we can improve the accuracy of our assessments and provide more personalized care. Our team is dedicated to advancing this field and helping patients receive the best possible outcomes

WHY CANDES AI

Artificial Intelligence +

Bioinformatics =

Candes AI

Our technologies enable us to offer the best solution by leveraging our proprietary Artificial Intelligence framework, which utilizes complex AI algorithms, including generative AI, to coalesce high-dimensional disease and drug properties. This approach, combined with multimodal machine learning and advanced bioinformatics, enables us to discover new targets, treatment criteria, and novel biomarkers to improve patients' diagnostic and treatment outcomes. Our analyses run in a highly scalable and secure infrastructure environment developed in-house with cutting-edge technologies, ensuring efficient and safe analysis of vast amounts of data. Our platform, namely HypaHub, is HIPAA compliant, safeguarding all sensitive data. These capabilities allow us to provide the best solution for our clients and contribute to the advancement of healthcare.

Our Cancer Models

1.5PB

DATA SIZE

95M

ANNOTATIONS

120M

PARAMETERS

99.9%

AUC

COLLABORATIONS

Our
Partners

We collaborate with leading academic institutions in scientific research and partnering with renowned biotech companies in data science to advance biomedical research in diagnostics and therapeutics. Join us in our mission to drive innovation and progress in the field of biomedicine.